Publicerad: 2021-05-26 15:45 | Uppdaterad: 2021-05-26 15:53

Aktuella utlysningar, vecka 21, 2021

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Research funding – Bröstcancerförbundet

These grants support breast cancer research with patient-centred clinical grounding. Projects are supported for up to three years.

Closing date: 4 June 2120

Further information

Postdoctoral scholarships – Swedish Brain Foundation (Hjärnfonden)

These support research on diseases, injuries and disabilities of the brain and other nervous systems, but also the healthy brain with its normal functions and development. Scholarships are worth up to SEK 300,000 over two years.

Closing date: 7 June 2021

Further information

Project grant: Research on disability – Swedish Research Council for Health, Working Life and Welfare (Forte)

This supports research that aim to contribute to wider and deeper knowledge of factors that prevent or promote participation by people with disabilities. Grants are worth between SEK 3million for two-year projects or SEK 4.5million for three-year projects.

Closing date: 22 June 2021

Further information

Network grants – Swedish Research Council for Health, Working Life and Welfare (Forte) 

These aim to make it easier for researchers from different disciplines and parts of the country to collaborate. Grants are worth SEK 150,000 per year for up to three years.

Closing date: 29 June 2021

Further information

Projekt utlysning av medel för alkoholforskning – Systembolagets Alkoholforskningsråd

Systembolagets Alkoholforskningsråd delar årligen ut anslag till olika forskningsprojekt. Samhällsvetenskaplig och medicinsk alkoholforskning stöds, forskning som är av särskild betydelse för det förebyggande arbetet mot alkoholskador prioriteras. Tio miljoner kronor delas ut varje år. Av dessa är två miljoner avsatta för av Systembolaget identifierade fokusområden och två miljoner kronor är avsatta till ansökningar från juniora forskare.

Closing date: 15 September 2021

Further information

Europeiska utlysningar

**New deadline** Marie Skłodowska-Curie Actions (MSCA) Upcoming Postdoctoral Fellowships 2021


The opening date for the MSCA 2021 Postdoctoral Fellowships program is delayed and will open on June 22, 2021. You can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.

Closing date: 12 October 2021 (new deadline)

Further information

Grants Office organized an information webinar aimed at KI employees and KI associated researchers, as well as researchers who plan to apply with KI as host organization. You can access the webinar here https://staff.ki.se/msca-postdoc-fellowships-info-webinar-2021

 

ECCO pioneer award - European Crohn's and Colitis Organisation

The European Crohn’s and Colitis Organisation invites proposals for its pioneer award. This aims to encourage and support innovative basic or clinical scientific research in the area of inflammatory bowel diseases across Europe. Projects must be new, original and not yet be launched.

A multi-centre project group or a single centre may apply. All applicants must be members of the organisation.

Two awards €300,000 each for a duration of two years are available.

Closing date: 02 Aug 2021

Further information

Anniversary fund - European Association for the Study of Diabetes

The European Association for the Study of Diabetes invites applications for its anniversary fund. This supports investigators in the fields of diabetes research in Europe in conducting translational or clinical research on diabetes or its comorbidities and complications.

Applicants must be members of the society. Basic scientists must be within 15 years of receiving their highest degree while clinicians must be within 17 years of receiving their highest degree. Clinicians holding more than one qualifying degree or with a clinical specialist degree or board certification, may be within 20 years of receiving their first degree. The principal investigator and any co-investigators must be employed full-time at a non-profit institution. Grants are worth up to €300,000 each.

Closing date: 16 August 2021

Further information

Workshops - European Molecular Biology Organisation

The European Molecular Biology Organisation invites applications for its grants to support workshops. These enable the organisation of workshops that cover different and evolving aspects of life-science related subject areas, and bring scientists together to present their findings.

Workshops must take place in an EMBC members state, an EMBC associate member state or cooperating partner countries. In rare cases, EMBO may consider applications for workshops taking place in other regions of the world. Workshops should last between two and a half and five days and attract between 80 and 450 participants.

Up to €39,000 is available per workshop, where €4,500 are allocated to travel grants and registration fee waivers and €1,000 for child care grants.

Closing date: 01 August 2021

Further information

Amerikanska utlysningar

Federal Funding agencies

Multiple sclerosis research programme – early investigator research award - Department of Defense, US

The US Department of Defense, under its multiple sclerosis research programme, invites pre-applications for its early investigator research award. This supports early-career investigators in developing a research project and investigating a problem in multiple sclerosis (MS) research under the guidance of one or more designated mentors. Applications must address at least one of the following focus areas:

  • central nervous system regenerative potential in demyelinating conditions;
  • correlates of disease activity and progression in MS;
  • biology and measurement of MS symptoms;
  • factors contributing to MS etiology, prodrome, onset and disease course;
  • interactions between MS and COVID-19.

The PI must have obtained a doctoral degree or equivalent from an accredited institution and have no more than four years of postdoctoral experience at the time of application.

The budget is USD 1.9 million, to fund six awards. Awards are worth up to USD 200,000 each in direct costs for a maximum of two years.

Closing date:  October 01, 2021 

Funding Opportunity Number: W81XWH-21-MSRP-EIRA

Further information 

Biomarkers for diabetic foot ulcers through the Diabetic Foot Consortium (R61/R33 clinical trial not allowed), NIH

The purpose of this Funding Opportunity Announcement is to promote the development of prognostic, monitoring, and diagnostic biomarkers that can be used in clinical care and clinical trials of diabetic foot ulcers (DFUs). This initiative would support early analytical and clinical validation of biomarkers through a phased award to encourage innovative research. The initiative would leverage the resources of the Diabetic Foot Consortium (DFC) to facilitate access to well-characterized patients and foot ulcers and high-quality human samples. The goal of this initiative is to deliver candidate biomarkers that are ready for definitive analytical and clinical validation studies through the Diabetic Foot Consortium.

Closing date: Letter of Intent October 3, 2021; Application Due Date November 03, 2021 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA):  RFA-DK-21-001

Further information 

NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional), NIH

The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. The scope of NLM's interest in these research domains is broad, with emphasis on new methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, reusable approaches to discovery, curation, analysis, organization and management of health-related digital objects. Biomedical informatics and data science draw upon many fields, including mathematics, statistics, information science, computer science and engineering, and social/behavioral sciences. Application domains include health care delivery, basic biomedical research, clinical and translational research, precision medicine, public health, biosurveillance, health information management in disasters, and similar areas. NLM defines biomedical informatics as the science of optimal representation, organization, management, integration and presentation of information relevant to human health and biology. NIH defines data science as the interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are developed and used to extract knowledge and insights from increasingly large and/or complex sets of data.

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-18-896

Further information 

Discovery of in vivo chemical probes for the nervous system (R01 clinical trial not allowed), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (“validated hits”) for chemical optimization and bioassays for testing new analog compounds.

Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIDA, NEI, and/or NIA and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes.

The main emphasis of projects submitted under this FOA should be the discovery of in vivo chemical probes. Applicants interested in developing cell-based chemical probes may wish to apply using the companion R21 mechanism, (PAR-21-028).

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-21-029 (R01), PAR-21-028 (R21)

Further information (R01)

Further information (R21

 

Foundations

Pilot and feasibility awards- Cystic Fibrosis Foundation, US

The Cystic Fibrosis Foundation invites applications for its pilot and feasibility awards. These support projects that will develop and test new hypotheses or new methods, and promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. The aim is to enable investigators to collect sufficient data to compete successfully for support from the NIH or other funding agencies. Special consideration is given to projects that propose innovative and creative approaches to the problems of CF.

Budget: Support may be requested for $50,000 per year (plus 12 percent for indirect costs) for up to two years.

Closing date: December 7, 2021

Further information